Home › Funds › Flower City Capital › IMRX

Flower City Capital position in IMRX

IMMUNEERING CORP · Health Care

Flower City Capital reported holding 60,029 shares of IMRX (IMMUNEERING CORP) in its Q3 2026 13F filing — a position valued at US$246K, representing 0.11% of its reported portfolio and ranking #38 among its reported holdings. Flower City Capital has disclosed IMRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)60.03K sh
Reported value held$245.82K
Portfolio Weight0.11%
First reportedQ2 2025
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Flower City Capital's IMRX position evolved

Flower City Capital first disclosed a stake in IMRX in Q2 2025 at 32,029 shares (US$108K). The position peaked in Q1 2026 at 55,029 shares, worth US$290K. Across 6 filings, Flower City Capital increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 60,029 shares valued at US$246K — an increase of 5,000 shares quarter over quarter.. Notable position changes include a 44% increase in Q4 2025 (shares fell 20% over the following quarter), a 30% increase in Q1 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 32.03K $107.94K New
Q3 2025 29.23K $204.60K Reduce
Q4 2025 42.23K $277.87K Add
Q1 2026 55.03K $290.00K Add
Q2 2026 55.03K $274.60K Hold
Q3 2026 60.03K $245.82K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMRX and 13F data

IMRX (IMMUNEERING CORP) is a Health Care company. 60 other funds we track also report a position in IMRX — the largest reported positions include Sanofi (US$13.5M), DCF Advisers, LLC (US$3.9M), ALETHEA CAPITAL MANAGEMENT, LLC (US$2.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMRX

All IMRX fund holders →

FAQ

How long has Flower City Capital held IMRX?

Flower City Capital has disclosed IMRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Flower City Capital's current position in IMRX?

As of Q3 2026, Flower City Capital holds 60.03K shares of IMRX (IMMUNEERING CORP), valued at $245.82K, representing 0.11% of its reported portfolio and ranking #38.

Has Flower City Capital been buying or selling IMRX?

In the latest 13F filing (Q3 2026), Flower City Capital increased its position in IMRX. The position peaked in Q1 2026 at 55.03K shares.

Which other funds hold IMRX?

Other major institutional holders of IMRX include Sanofi, DCF Advisers, LLC, ALETHEA CAPITAL MANAGEMENT, LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.